| An overview of targeted alpha therapy with 225Actinium and 213Bismuth A Morgenstern, C Apostolidis, C Kratochwil, M Sathekge, L Krolicki, ... Current radiopharmaceuticals 11 (3), 200-208, 2018 | 306 | 2018 |
| 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study M Sathekge, F Bruchertseifer, O Knoesen, F Reyneke, I Lawal, T Lengana, ... European journal of nuclear medicine and molecular imaging 46, 129-138, 2019 | 301 | 2019 |
| Antimicrobial peptides: their role as infection-selective tracers for molecular imaging T Ebenhan, O Gheysens, HG Kruger, JR Zeevaart, MM Sathekge BioMed research international 2014, 2014 | 237 | 2014 |
| Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study FL Giesel, L Will, I Lawal, T Lengana, C Kratochwil, M Vorster, O Neels, ... Journal of Nuclear Medicine 59 (7), 1076-1080, 2018 | 176 | 2018 |
| Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours C Van de Wiele, V Kruse, P Smeets, M Sathekge, A Maes European journal of nuclear medicine and molecular imaging 40, 290-301, 2013 | 167 | 2013 |
| Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area MM Sathekge, A Maes, H Pottel, A Stoltz, C Van De Wiele South African medical journal 100 (9), 598-561, 2010 | 162 | 2010 |
| Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 61 (1), 62-69, 2020 | 159 | 2020 |
| Extraordinary arousal from semi-comatose state on zolpidem RP Clauss, WM Güldenpfennig, HW Nel, MM Sathekge, ... South African Medical Journal 90 (1), 68-72, 2000 | 143 | 2000 |
| 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer M Sathekge, O Knoesen, M Meckel, M Modiselle, M Vorster, S Marx European Journal of Nuclear Medicine and Molecular Imaging 44, 1099-1100, 2017 | 140 | 2017 |
| Advances in imaging of tuberculosis: the role of: 18: F-FDG PET and PET/CT M Vorster, MM Sathekge, J Bomanji Current opinion in pulmonary medicine 20 (3), 287-293, 2014 | 132 | 2014 |
| PET/CT imaging of Mycobacterium tuberculosis infection AO Ankrah, TS van der Werf, EFJ de Vries, RAJO Dierckx, MM Sathekge, ... Clinical and Translational Imaging 4, 131-144, 2016 | 124 | 2016 |
| Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients FL Giesel, C Kratochwil, J Schlittenhardt, K Dendl, M Eiber, F Staudinger, ... European journal of nuclear medicine and molecular imaging 48 (13), 4377-4385, 2021 | 123 | 2021 |
| FDG-PET imaging in HIV infection and tuberculosis M Sathekge, A Maes, C Van de Wiele Seminars in nuclear medicine 43 (5), 349-366, 2013 | 115 | 2013 |
| 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients M Sathekge, T Lengana, M Modiselle, M Vorster, JR Zeevaart, A Maes, ... European journal of nuclear medicine and molecular imaging 44, 689-694, 2017 | 112 | 2017 |
| Evaluation of thyroid nodules with technetium‐99m MIBI and technetium‐99m pertechnetate MM Sathekge, RB Mageza, MN Muthuphei, MCM Modiba, RC Clauss Head & neck 23 (4), 305-310, 2001 | 111 | 2001 |
| 68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? T Lengana, IO Lawal, TG Boshomane, GO Popoola, KMG Mokoala, ... Clinical genitourinary cancer 16 (5), 392-401, 2018 | 109 | 2018 |
| Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis M Sathekge, A Maes, M Kgomo, A Stoltz, C Van de Wiele Journal of Nuclear Medicine 52 (6), 880-885, 2011 | 107 | 2011 |
| 68Ga-FAPI-PET/CT in patients with various gynecological malignancies K Dendl, SA Koerber, R Finck, KMG Mokoala, F Staudinger, L Schillings, ... European journal of nuclear medicine and molecular imaging 48 (12), 4089-4100, 2021 | 101 | 2021 |
| Development and prospects of dedicated tracers for the molecular imaging of bacterial infections A Bunschoten, MM Welling, MF Termaat, M Sathekge, FWB Van Leeuwen Bioconjugate chemistry 24 (12), 1971-1989, 2013 | 96 | 2013 |
| COVID-19 pandemic: guidance for nuclear medicine departments D Paez, G Gnanasegaran, S Fanti, J Bomanji, M Hacker, M Sathekge, ... European journal of nuclear medicine and molecular imaging 47, 1615-1619, 2020 | 95 | 2020 |
